探索多种代谢物对卵巢癌的因果作用:一个两样本的门德尔随机化研究
Shaoxuan Liu1, Danni Ding1, Fangyuan Liu2
1First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
Journal of ovarian research
|January 23, 2024
概括
这项研究使用了门德尔的随机化来识别与卵巢癌 (OC) 风险和亚型相关的遗传决定性代谢物. 结果揭示了保护性和与风险相关的代谢物,表明了OC的潜在生物标志物.
科学领域:
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 流行病学 流行病学
背景情况:
- 卵巢癌 (OC) 的机制和危险因素需要进一步研究.
- 循环中的代谢物显示出作为OC生存的预后生物标志物的前景.
- 有限的研究存在于OC病原和亚型中代谢物的遗传决定因素.
研究的目的:
- 研究遗传决定性代谢物 (GDM) 与卵巢癌 (OC) 风险之间的因果关系.
- 探索GDM与不同OC亚型之间的关联.
- 为了确定OC的潜在预后生物标志物.
主要方法:
- 一个采用两样本的孟德尔随机化 (MR) 研究,利用全基因组关联研究 (GWAS) 数据.
- 逆方差加权 (IVW) 方法作为主要分析,使用MR-Egger和加权中位数进行验证.
- 进行了敏感性分析,包括MR-Egger拦截和Cochran的Q,以评估异质性和性. 使用MetaboAnalyst 5.0.0.进行了代谢途径分析.
主要成果:
- 确定了14种代谢物和OC风险之间的18种诱导性因果关联.
- 八种代谢物与OC风险增加有关,而六种具有保护作用.
- 特定的代谢途径,包括咖啡因代谢,阿基宁生物合成和TCA循环,与粘膜性卵巢癌 (MOC) 和子宫内膜卵巢癌 (OCED) 有关.
结论:
- 遗传决定的代谢物在卵巢癌中表现出保护性和风险相关的作用.
- 代谢途径与特定的OC亚型有显著的关联.
- 已识别的代谢物代表了新型OC生物标志物的潜在候选者.
相关概念视频
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K


